Tokyo - Delayed Quote JPY

Tsubota Laboratory Incorporated (4890.T)

374.00
-7.00
(-1.84%)
At close: 3:30:00 PM GMT+9
Loading Chart for 4890.T
  • Previous Close 381.00
  • Open 381.00
  • Bid 373.00 x --
  • Ask 374.00 x --
  • Day's Range 370.00 - 381.00
  • 52 Week Range 284.00 - 625.00
  • Volume 98,500
  • Avg. Volume 157,740
  • Market Cap (intraday) 9.566B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 23.88
  • EPS (TTM) 15.66
  • Earnings Date May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Tsubota Laboratory Incorporated engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. The company was incorporated in 2012 and is based in Tokyo, Japan.

www.tsubota-lab.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 4890.T

View More

Performance Overview: 4890.T

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4890.T
3.86%
Nikkei 225 (^N225)
4.43%

1-Year Return

4890.T
1.06%
Nikkei 225 (^N225)
0.59%

3-Year Return

4890.T
52.90%
Nikkei 225 (^N225)
44.27%

5-Year Return

4890.T
52.90%
Nikkei 225 (^N225)
91.46%

Compare To: 4890.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4890.T

View More

Valuation Measures

Annual
As of 5/13/2025
  • Market Cap

    9.75B

  • Enterprise Value

    8.02B

  • Trailing P/E

    24.33

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.57

  • Price/Book (mrq)

    6.66

  • Enterprise Value/Revenue

    6.21

  • Enterprise Value/EBITDA

    18.33

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.11%

  • Return on Assets (ttm)

    6.15%

  • Return on Equity (ttm)

    13.88%

  • Revenue (ttm)

    1.36B

  • Net Income Avi to Common (ttm)

    205M

  • Diluted EPS (ttm)

    15.66

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.54B

  • Total Debt/Equity (mrq)

    5.67%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 4890.T

View More

Company Insights: 4890.T

Research Reports: 4890.T

View More

People Also Watch